Search

Sarepta Therapeutics anuncia quinto año de Route 79, El Programa de Becas Duchenne
Addressing your questions about COVID-19 vaccination and gene therapy
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Community Bulletin for the LGMD 2B/R2 Community
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments
LGMD Grant Award Program
Sarepta Therapeutics Launches Inaugural LGMD Grant Award Program